Contributors

Add your signal.

We publish original analysis from operators, investors, clinicians, regulators, and researchers who have something useful to say.

If you have company news, a product launch, or a funding announcement, please use our Press Releases page instead.

What we publish

Original analysis

A clear point of view on a healthtech market, regulation, business model, or clinical workflow. The reader should finish the piece understanding something new.

First-hand experience

Lessons from building, funding, regulating, or delivering healthcare technology. We prefer specifics over general advice.

Data-driven commentary

Interpretation of published data, filings, guidance, trials, or market signals, with sources a reader can check.

Case studies

A detailed look at how one company, health system, or market handled a real decision, including what worked and what did not.

What we do not publish

Product launches, funding announcements, and company news

Those belong on our Press Releases page. If you have company news to share, please submit it there instead.

Promotional or sales-focused copy

We do not publish pieces whose main purpose is to generate leads, place backlinks, or promote a service.

Content published elsewhere

We publish original work that has not appeared on another site, newsletter, or LinkedIn article.

Ghostwritten or agency-submitted copy

The named author must be the person who wrote the piece. Communications teams may help with formatting, but the byline is personal.

Negative coverage of individuals or companies

We cover companies and products, not private lives, controversies, or attacks.

Format and length

  • Length800 to 1,500 words. Shorter pitches are fine; longer pieces need a strong reason.
  • ToneClear, direct, and respectful of the reader's time. Avoid jargon unless you explain it.
  • StructureStart with the argument. Use headings, short paragraphs, and bullet points where they help.
  • SourcesLink to filings, studies, guidance documents, or data you reference. We verify claims before publishing.
  • DisclosureList every relevant interest: employer, clients, advisory roles, investments, and board seats.
  • Author bioOne to two sentences on who you are and why you are qualified to write this.

What happens after you submit

An editor reviews every draft. We may accept it, suggest changes, or decline it with a note. If we accept it, we edit for clarity and accuracy, check every claim with you, and then publish it under your byline with your photo, bio, and links.

Most responses arrive within five working days. Contributions are unpaid unless we commission you directly.

Submit your full draft

You can also apply first through Write for us if you would rather send a pitch before writing the full piece.

Every draft is reviewed. Submission does not guarantee publication.